Matches in Wikidata for { <http://www.wikidata.org/entity/Q92547026> ?p ?o ?g. }
- Q92547026 description "article scientifique publié en 2019" @default.
- Q92547026 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92547026 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92547026 description "scientific article published on 04 June 2019" @default.
- Q92547026 description "wetenschappelijk artikel" @default.
- Q92547026 description "наукова стаття, опублікована 4 червня 2019" @default.
- Q92547026 name "Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAP" @default.
- Q92547026 name "Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAP" @default.
- Q92547026 type Item @default.
- Q92547026 label "Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAP" @default.
- Q92547026 label "Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAP" @default.
- Q92547026 prefLabel "Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAP" @default.
- Q92547026 prefLabel "Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAP" @default.
- Q92547026 P1433 Q92547026-1CE6C3EE-1300-4DB1-8503-F8A7CA2486F1 @default.
- Q92547026 P1476 Q92547026-48D62FA0-B618-4D38-B1AC-DE2819F5BDA1 @default.
- Q92547026 P2093 Q92547026-09E9282A-71B7-4775-BC49-4310D926CCDA @default.
- Q92547026 P2093 Q92547026-202254B5-7654-435F-B519-10C4A5E39904 @default.
- Q92547026 P2093 Q92547026-3D0A11A2-ECAF-466D-90D2-9896486E8906 @default.
- Q92547026 P2093 Q92547026-4CB2D93E-138F-468E-808E-2AFFECA75CC5 @default.
- Q92547026 P2093 Q92547026-E22D66E3-90B9-44B0-928C-95F968A9D3A9 @default.
- Q92547026 P2093 Q92547026-ED94AF74-DFB1-4174-A285-2F325BEA4DBE @default.
- Q92547026 P2093 Q92547026-FA2CA0E0-E590-4AEE-8881-6AF0EBA9BD34 @default.
- Q92547026 P2860 Q92547026-01BE241D-A5F0-414D-8F62-3362CBA78BD5 @default.
- Q92547026 P2860 Q92547026-343218F6-FDBB-459D-8C45-12D86175664C @default.
- Q92547026 P2860 Q92547026-3C052032-D53E-4A0A-9999-C9323EC84BAB @default.
- Q92547026 P2860 Q92547026-3C195F5E-A8CC-4233-9D25-4EB920831524 @default.
- Q92547026 P2860 Q92547026-410B125F-0854-4FC9-95E0-4A803BA27460 @default.
- Q92547026 P2860 Q92547026-427F6239-FE71-427F-8D04-322236B58DC6 @default.
- Q92547026 P2860 Q92547026-480005A7-ECB6-48DF-ABAD-E40CEF64C285 @default.
- Q92547026 P2860 Q92547026-578E5464-C509-49BA-BE9B-73FCD89345F2 @default.
- Q92547026 P2860 Q92547026-5CE624B2-F9EB-4B52-A2BA-9216C903A0D4 @default.
- Q92547026 P2860 Q92547026-736DCAF3-EA31-49A1-A833-6A84A7EBA711 @default.
- Q92547026 P2860 Q92547026-7A691BF0-9048-40F5-A1E5-AB941849A49E @default.
- Q92547026 P2860 Q92547026-86CE5DCD-8E67-4238-BD70-68FBE6DBBC21 @default.
- Q92547026 P2860 Q92547026-923457A1-C3C0-423A-A4B4-BAD55531CF1B @default.
- Q92547026 P2860 Q92547026-A088CCCA-27F4-4989-BDBC-AC107D763902 @default.
- Q92547026 P2860 Q92547026-A0B33C3B-EA48-4758-8DFD-C9C883A26C30 @default.
- Q92547026 P2860 Q92547026-B03AE9C9-F77A-4EFA-A290-FA25E7B30E2F @default.
- Q92547026 P2860 Q92547026-BBAD714D-4DA8-40DC-8EC0-BFA2A543D460 @default.
- Q92547026 P2860 Q92547026-C14CB4C0-6A07-41B2-AB32-CB8C561870F0 @default.
- Q92547026 P2860 Q92547026-CBFB09A0-E766-4E13-938D-EF1F6302C29C @default.
- Q92547026 P2860 Q92547026-E323AAF0-BDA7-4E6E-BC22-D40F98F9B05C @default.
- Q92547026 P2860 Q92547026-ECD2A998-4FF5-40E0-BC97-89C20EBC5378 @default.
- Q92547026 P2860 Q92547026-F8198F48-3131-49EF-B45F-17830348DD74 @default.
- Q92547026 P304 Q92547026-50E1775D-5D85-4A25-A9F4-529DABCB6012 @default.
- Q92547026 P31 Q92547026-F3FD5CC0-511A-48CE-B412-5DE017898229 @default.
- Q92547026 P356 Q92547026-71E4098F-0087-43F9-B488-5A7D64B804E6 @default.
- Q92547026 P433 Q92547026-F83EC4B3-0BBD-4C15-AD88-4804DCE95FAC @default.
- Q92547026 P478 Q92547026-D7663B8D-434F-4370-825B-29F4C758D045 @default.
- Q92547026 P50 Q92547026-1C13B73F-FBEE-4F83-AF2E-996798BEE5C6 @default.
- Q92547026 P50 Q92547026-3F02C04E-F0C3-4907-92D3-A8F6725C4802 @default.
- Q92547026 P50 Q92547026-555B54F8-118C-4EAC-A690-7033F8A69B31 @default.
- Q92547026 P50 Q92547026-91FDC27F-644E-48CD-B502-4F1816CA53AC @default.
- Q92547026 P50 Q92547026-92A68F2F-0328-4096-9A52-8E022EFCBDC0 @default.
- Q92547026 P50 Q92547026-9E18750E-D8D9-4854-95EE-524161D912BC @default.
- Q92547026 P50 Q92547026-C0CB647F-52D6-4180-9051-96C4C230D6AC @default.
- Q92547026 P577 Q92547026-FA1E7D3D-4E39-47B0-ADBA-13CC5F7A7C44 @default.
- Q92547026 P698 Q92547026-412FD74E-1C62-4386-B262-A0200352E740 @default.
- Q92547026 P921 Q92547026-5CCDB546-EFE1-45FB-A4AE-1F5A723E07D3 @default.
- Q92547026 P932 Q92547026-A8E2E389-2144-4091-AD9D-A5D95C474621 @default.
- Q92547026 P356 BMJOPEN-2019-029388 @default.
- Q92547026 P698 31167875 @default.
- Q92547026 P1433 Q17003470 @default.
- Q92547026 P1476 "Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAPTT Study)" @default.
- Q92547026 P2093 "Andrew Mumford" @default.
- Q92547026 P2093 "Barnaby C Reeves" @default.
- Q92547026 P2093 "Chris A Rogers" @default.
- Q92547026 P2093 "Jessica Harris" @default.
- Q92547026 P2093 "Sabi Redwood" @default.
- Q92547026 P2093 "Sarah Wordsworth" @default.
- Q92547026 P2093 "Yoon Loke" @default.
- Q92547026 P2860 Q28214184 @default.
- Q92547026 P2860 Q28645951 @default.
- Q92547026 P2860 Q29619002 @default.
- Q92547026 P2860 Q33476068 @default.
- Q92547026 P2860 Q34076164 @default.
- Q92547026 P2860 Q34134730 @default.
- Q92547026 P2860 Q35095095 @default.
- Q92547026 P2860 Q37148386 @default.
- Q92547026 P2860 Q37335426 @default.
- Q92547026 P2860 Q37362822 @default.
- Q92547026 P2860 Q37657795 @default.
- Q92547026 P2860 Q37889006 @default.
- Q92547026 P2860 Q38171360 @default.
- Q92547026 P2860 Q38231091 @default.
- Q92547026 P2860 Q38440161 @default.
- Q92547026 P2860 Q38520298 @default.
- Q92547026 P2860 Q43077321 @default.
- Q92547026 P2860 Q46209759 @default.
- Q92547026 P2860 Q46915044 @default.
- Q92547026 P2860 Q57153950 @default.
- Q92547026 P2860 Q57621041 @default.
- Q92547026 P2860 Q84198464 @default.
- Q92547026 P304 "e029388" @default.
- Q92547026 P31 Q13442814 @default.
- Q92547026 P356 "10.1136/BMJOPEN-2019-029388" @default.
- Q92547026 P433 "6" @default.
- Q92547026 P478 "9" @default.
- Q92547026 P50 Q37830219 @default.
- Q92547026 P50 Q56550924 @default.